Skip to Main Content

Author Details

Egbert Bisping
Medical University of Graz
2001
35
19
PMIDPaper TitleJournal TitlePublished Year
37231701The value of clinical routine blood biomarkers in predicting long-term mortality after stroke.Eur Stroke J2023
34519135Predicting atrial fibrillation after cryptogenic stroke via a clinical risk score-a prospective observational study.Eur J Neurol2022
35805966miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium.Int J Mol Sci2022
35616058Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity.Circulation2022
35485970Liver Fibrosis-4 index indicates atrial fibrillation in acute ischemic stroke.Eur J Neurol2022
34953495Post-cardiac injury syndrome triggered by radiofrequency ablation for AVNRT.BMC Cardiovasc Disord2021
33869728Expert consensus on acute management of ventricular arrhythmias - VT network Austria.Int J Cardiol Heart Vasc2021
33508338No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.Int J Cardiol2021
33886660Impact of electric cardioversion on platelet activation.PLoS One2021
32393291Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging - a case report.BMC Pediatr2020
32573098The role of stretch, tachycardia and sodium-calcium exchanger in induction of early cardiac remodelling.J Cell Mol Med2020
31216968Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.Stroke2019
30532216Is there a difference in rhythm outcome between patients undergoing first line versus second line paroxysmal atrial fibrillation ablation?PLoS One2018
30062428Crosstalk between FGF23- and angiotensin II-mediated Ca<sup>2+</sup> signaling in pathological cardiac hypertrophy.Cell Mol Life Sci2018
28394258Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function.J Clin Invest2017
24315909Subclinical abnormalities in sarcoplasmic reticulum Ca(2+) release promote eccentric myocardial remodeling and pump failure death in response to pressure overload.J Am Coll Cardiol2014
25286359Targeting cardiac hypertrophy: toward a causal heart failure therapy.J Cardiovasc Pharmacol2014
25268295Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.JAMA2014
24928680Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure.Circulation2014
22228770Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.J Biol Chem2012
22923418Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene.Circ Cardiovasc Genet2012
20883803CMV promoter is inadequate for expression of mutant human RyR2 in transgenic rabbits.J Pharmacol Toxicol Methods2011
20083620Functional effects of glucose transporters in human ventricular myocardium.Eur J Heart Fail2010
20124440Heart failure-associated changes in RNA splicing of sarcomere genes.Circ Cardiovasc Genet2010
19237664Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy.Circulation2009
17468330Uncoupling protein 2 modulates cell viability in adult rat cardiomyocytes.Am J Physiol Heart Circ Physiol2007
17956764Mechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardium.Eur J Heart Fail2007
17712037Altered microRNA expression in human heart disease.Physiol Genomics2007
17766467Atrial myocardium is the predominant inotropic target of adrenomedullin in the human heart.Am J Physiol Heart Circ Physiol2007
16469847Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.FASEB J2006
16762803Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.J Card Fail2006
16857965Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition.Circ Res2006
16983087Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure.Proc Natl Acad Sci U S A2006
14597618The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.J Biol Chem2004
11327339Influence of mild hypothermia on myocardial contractility and circulatory function.Basic Res Cardiol2001
  • 1 - 35 of 35

Recommended Authors

University of Virginia Health System
Career Start Year 2008
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 1
Gladstone Institutes San Francisco
Career Start Year 2004
Number of shared co-authors 0
Division of Clinical Laboratory Medicine, Hyogo College of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of California davis
Career Start Year 2001
Number of shared co-authors 0
Vanderbilt University
Career Start Year 2001
Number of shared co-authors 1
Collegeville
Career Start Year 2000
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1999
Number of shared co-authors 3
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 2
Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 5
University of California san francisco
Career Start Year 1995
Number of shared co-authors 0
University of Washington
Career Start Year 1993
Number of shared co-authors 0
University of California los angeles
Career Start Year 1993
Number of shared co-authors 0
Stanford University
Career Start Year 1993
Number of shared co-authors 7
National and Kapodistrian University of Athens, Attikon University Hospital
Career Start Year 1993
Number of shared co-authors 1
Cardiovascular Research Center, Massachusetts General Hospital
Career Start Year 1989
Number of shared co-authors 26
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Career Start Year 1988
Number of shared co-authors 1
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 23
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1986
Number of shared co-authors 1
University of Maryland
Career Start Year 1986
Number of shared co-authors 1
Center for Molecular Medicine, Maine Medical Center Research Institute
Career Start Year 1985
Number of shared co-authors 7
University of Colorado Anschutz Medical Campus
Career Start Year 1983
Number of shared co-authors 1
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 1
Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University
Career Start Year 1979
Number of shared co-authors 4
Saint Joseph Hospital, Paris-Sorbonne University
Career Start Year 1978
Number of shared co-authors 6
Biostatistics and Prevention Institute, University of Zurich
Career Start Year 1976
Number of shared co-authors 0
Brigham and Women's Hospital (Y.K.
Career Start Year 1975
Number of shared co-authors 14
University Hospital Wurzburg
Career Start Year 1974
Number of shared co-authors 4
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Charite University Medicine, Berlin Institute of Health (BIH)
Co-authored papers 14
Boston Children's Hospital, Harvard Medical School
Co-authored papers 8
Baker Heart and Diabetes Institute
Co-authored papers 4
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers 4
Beth Israel Deaconess Medical Center.
Co-authored papers 4
Tokyo Medical and Dental University Hospital
Co-authored papers 4
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 4
Beth Israel Deaconess Medical Center
Co-authored papers 3
Novartis Institutes for BioMedical Research, Inc. Cambridge
Co-authored papers 3
Harvard Medical School, Boston Children's Hospital.
Co-authored papers 2
University of Michigan School of Public Health ann arbor
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Yale University
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Benioff Children's Hospital, University of California san francisco
Co-authored papers 1
University Medical Center Rotterdam
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Beth Israel Deaconess Medical Center.
Co-authored papers 1
German Research Center for Environmental Health
Co-authored papers 1
Co-authored papers 1
Conway Institute of Biomolecular and Biomedical Research, University College Dublin
Co-authored papers 1
University Medical Center Gottingen
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
Finnish Cardiovascular Research Center-Tampere - FCRCT, Tampere University
Co-authored papers 1